Johnson & Johnson Earnings Preview
Thu, Jul 15, 12:14 PM ET, by EarningsPreviews.com
Johnson & Johnson's track record indicates that they will deliver another solid quarter. Johnson & Johnson (JNJ: 60.16 -0.76%) is scheduled to report their second quarter 2010 results before the market opens on Tuesday, July 20. JNJ has a tremendous track record of delivering earnings results that exceed Wall Street's consensus estimates. Last quarter, the pharmaceutical giant reported earnings results that were $.02 above Wall Street's consensus estimates. JNJ shares were essentially unchanged following the earnings announcement. The current Wall Street consensus estimates are for revenues of $15.68 billion and EPS of $1.21. This would imply a 3% increase in revenues over last year's $15.24 billion. Analysts expect an even bigger increase in profits. Johnson & Johnson shares have fallen 6% this year, but have outperformed the 3% decline in the S&P 500 index. Last year, JNJ shares gained nearly 8%, but underperformed the 23% gain in the S&P 500. Johnson & Johnson stock is currently trading at 12x consensus 2011 EPS estimates. Johnson & Johnson will likely deliver another solid quarter and provides investors with one of the safer stocks in the Dow Jones index.
SDI Glossary: "Analyst" Definition
SDI Glossary: "EPS" Definition
This Article's Word Cloud:
Analysts
Johnson
July
Last
Street
Tuesday
Wall
above
another
billion
consensus
currently
deliver
delivering
earnings
estimates
exceed
fallen
following
gain
giant
have
increase
index
investors
likely
market
nearly
opens
outperformed
pharmaceutical
quarter
record
results
revenues
safer
second
shares
solid
stocks
that
track
trading
tremendous
unchanged
were
will
with
would
year
More articles: 1 2 3 next »
| 
RSS
